COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

•A MS patient treated with ocrelizumab healed from COVID-19 without consequences•Immunosuppression might have played favorable role•This report supports the use of immunosuppressants in serious COVID-19 c Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the wo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis and related disorders Jg. 42; S. 102120
Hauptverfasser:	Novi, Giovanni, Mikulska, Malgorzata, Briano, Federica, Toscanini, Federica, Tazza, Francesco, Uccelli, Antonio, Inglese, Matilde
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands Elsevier B.V 01.07.2020
Schlagworte:	Antibodies, Monoclonal, Humanized - therapeutic use Betacoronavirus Case Report Coronavirus Infections - complications Coronavirus Infections - physiopathology COVID-19 Humans Immunologic Factors - therapeutic use Male Middle Aged Multiple Sclerosis, Chronic Progressive - complications Multiple Sclerosis, Chronic Progressive - drug therapy Neurology Pandemics Pneumonia, Viral - complications Pneumonia, Viral - physiopathology Protective Factors SARS-CoV-2 Severity of Illness Index
ISSN:	2211-0348, 2211-0356, 2211-0356
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!